MGC Pharmaceuticals update on key clinical trial plans: CimetrA, CannEpil and
’s () () () Roby Zomer presents his trial plans to Proactive London. Zomer says the the clinical trial programs…
Read More...
Read More...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.
We respect your privacy and take protecting it seriously
Recover your password.
A password will be e-mailed to you.